From NAFLD to MASLD: When metabolic comorbidity matters Shan Hong; Lei Sun; Yiwei Hao; Ping Li; Yuling Zhou; Xiuxia Liang; Julong Hu; Hongshan Wei;

Blood pressure stratification for predicting liver fibrosis risk in metabolic dysfunction associated fatty liver disease Jing Liu; Haifeng Lv; Jie Wang; Qianru Zhu; Gongying Chen; Yanming Jiang; Ke Zhao; Li Shao; Junping Shi; Xiaoben Pan;

Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study Samantha Thifani Alrutz Barcelos; Amanda Souza Silva-Sperb; Helena Abadie Moraes; Larisse Longo; Bruna Concheski de Moura; Matheus Truccolo Michalczuk; Carolina Uribe-Cruz; Carlos Thadeu Schmidt Cerski; Themis Reverbel da Silveira; Valesca Dall'Alba; Mário Reis Álvares-da-Silva;